US Patent Issued to Eli Lilly and Co. on March 31 for "Compositions and methods of use of interleukin-10 in combination with immune check-point pathway inhibitors" (California Inventor)

ALEXANDRIA, Va., March 31 -- United States Patent no. 12,589,134, issued on March 31, was assigned to Eli Lilly and Co. (Indianapolis).

"Compositions and methods of use of interleukin-10 in combination with immune check-point pathway inhibitors" was invented by Martin Oft (Palo Alto, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure provides a method for the treatment of neoplastic disease in a mammalian subject the method comprising the administration of an IL-10 agent in combination with the administration of at least one modulator of at least one immune checkpoint pathway. The present disclosure further provides a method for the treatment of neoplastic disease wherein the neopla...